About Augere Medical
Augere Medical is a company based in Oslo (Norway) founded in 2018.. Augere Medical has raised $2.08 million across 1 funding round. The company has 4 employees as of December 31, 2019. Augere Medical offers products and services including PolypAID™. Augere Medical operates in a competitive market with competitors including PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others.
- Headquarter Oslo, Norway
- Employees 4 as on 31 Dec, 2019
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Augere Medical As
-
Annual Revenue
$580.62 K (USD)122as on Dec 31, 2021
-
Net Profit
-
EBITDA
-
Total Equity Funding
$2.08 M (USD)
in 1 rounds
-
Latest Funding Round
$2.08 M (USD), Seed
Nov 19, 2024
-
Investors
-
Employee Count
4
as on Dec 31, 2019
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Augere Medical
Augere Medical offers a comprehensive portfolio of products and services, including PolypAID™. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI tool for detecting polyps during colonoscopy procedures.
Funding Insights of Augere Medical
Augere Medical has successfully raised a total of $2.08M through 1 strategic funding round. The most recent funding activity was a Seed round of $2.08 million completed in November 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $2.1M
-
First Round
First Round
(19 Nov 2024)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2024 | Amount | Seed - Augere Medical | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by Augere Medical
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Augere Medical
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Augere Medical Comparisons
Competitors of Augere Medical
Augere Medical operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PathAI, Viz.ai, Deepcell, Deciphex and Aignostics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| domain | founded_year | HQ Location |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| domain | founded_year | HQ Location |
AI-powered single cell classification and isolation technology for clinical research
|
|
| domain | founded_year | HQ Location |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| domain | founded_year | HQ Location |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| domain | founded_year | HQ Location |
AI-based tools for pathological image analysis are provided to labs.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Augere Medical
Frequently Asked Questions about Augere Medical
When was Augere Medical founded?
Augere Medical was founded in 2018 and raised its 1st funding round 6 years after it was founded.
Where is Augere Medical located?
Augere Medical is headquartered in Oslo, Norway. It is registered at Oslo, Oslo, Norway.
Who is the current CEO of Augere Medical?
Andreas Petlund is the current CEO of Augere Medical.
Is Augere Medical a funded company?
Augere Medical is a funded company, having raised a total of $2.08M across 1 funding round to date. The company's 1st funding round was a Seed of $2.08M, raised on Nov 19, 2024.
How many employees does Augere Medical have?
As of Dec 31, 2019, the latest employee count at Augere Medical is 4.
What is the annual revenue of Augere Medical?
Annual revenue of Augere Medical is $580.62K as on Dec 31, 2021.
What does Augere Medical do?
Augere Medical was founded in 2018 in Oslo, Norway, within the medical technology sector. AI-driven devices are offered by the company for cancer detection, where video footage is analyzed in real-time during endoscopic procedures. Compatibility with equipment from various vendors is supported, and probabilities for early-stage lesions are delivered to endoscopists on the spot. Operations center on enhancing diagnostic accuracy in clinical settings.
Who are the top competitors of Augere Medical?
Augere Medical's top competitors include Aignostics, Deciphex and Pictor Labs.
What products or services does Augere Medical offer?
Augere Medical offers PolypAID™.